Tesla ends the week up 6.3% — its best weekly gain in months — yet the options market is quietly hedging more than usual, a split that frames the setup heading into the October 21 earnings date.
The most notable shift this week is in options positioning. Put demand has climbed relative to recent norms: the put/call ratio hit 0.80, running well above its 20-day average of 0.77 and reaching a z-score of 1.66 — the most defensive options posture seen in several weeks. That's not a panic reading, but it stands out precisely because it's arriving alongside a rally rather than a selloff. Traders are paying more for downside protection even as the stock bounces. The 52-week high on the PCR is 0.93, so there is room to run further if the hedging impulse strengthens into earnings.
Short interest tells a quieter story — and one that has changed since last week's note. The previous note flagged bears pausing after a short rebuild that took SI to 2.64% of the free float on September 11. That reversal has continued. SI now stands at 2.24% of free float, roughly where it sat after the initial post-July washout. The month-on-month increase of 10.8% shows the rebuild is real, but the week-on-week move is barely flat — bears added almost nothing net over the past five sessions. The borrow market remains wholly unthreatening. Availability is essentially unlimited. Cost to borrow ticked up 13% on the week to 0.38%, which is noise rather than signal at this absolute level. There is no squeeze pressure, no stress in the lending pool, and no urgency for shorts to cover.
The Street is split in a way that reflects genuine uncertainty about the growth trajectory. Goldman Sachs reiterated Neutral with a $360 target last week — below the current price of $378.90. Morgan Stanley holds Equal-Weight at $400, and JPMorgan sits at Neutral with a $445 target after cutting from $475 following the July earnings miss. The bull camp — Stifel at $491, Piper Sandler at $450, StoneX at $475 — is anchored in the long-term autonomous and energy storage thesis. GLJ Research remains the outlier with a $24.86 Sell, a target so far from the current price it warrants a caveat: it represents a structural bear case, not a near-term price call. The consensus rating is technically Sell with a mean target of $396.93, implying slim upside. Valuation multiples are demanding: trailing PE is 182x, price-to-book is 13.8x, and EV/EBITDA is 83x. The 30-day expansion in PE of roughly 9 points reflects the stock's partial recovery from the July shock rather than any improvement in the earnings picture. Factor scores underscore the tension — EPS momentum ranks in the 79th percentile on a 30-day basis but collapses to the 14th percentile over 90 days, capturing the post-July estimate cuts.
The earnings history adds the sharpest context of all. Tesla fell 15.6% the day after July's Q2 report and extended losses to 21.3% over the following five sessions. That print is now the shadow hanging over October 21. The 6.3% weekly gain this week means the stock has recovered a meaningful portion of the post-July damage, but it also means bulls are carrying more risk into a date where recent history is unambiguous in its direction. Peers offered little directional help this week: RIVN fell 2.6% and XPEV edged up 2.4%, leaving Tesla's rally looking more stock-specific than sector-driven.
Overall, the setup is one of recovery with unresolved risk: the short book has stopped rebuilding for now, the borrow market is loose, and the stock has found buyers — but options traders are adding protection into the bounce, and the October 21 print looms as the event that will settle whether the bears or bulls were right to fade the July overreaction.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
